• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单颗粒旋转微流变学可用于对泡沫巨噬细胞进行病理性分期和抗动脉粥样硬化研究。

Single-particle rotational microrheology enables pathological staging of macrophage foaming and antiatherosclerotic studies.

机构信息

State Key Laboratory for Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.

State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi University of Chinese Medicine, Xianyang 712083, China.

出版信息

Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2403740121. doi: 10.1073/pnas.2403740121. Epub 2024 Aug 5.

DOI:10.1073/pnas.2403740121
PMID:39102540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11331104/
Abstract

The formation of macrophage-derived foam cells has been recognized as the pathological hallmark of atherosclerotic diseases. However, the pathological evolution dynamics and underlying regulatory mechanisms remain largely unknown. Herein, we introduce a single-particle rotational microrheology method for pathological staging of macrophage foaming and antiatherosclerotic explorations by probing the dynamic changes of lysosomal viscous feature over the pathological evolution progression. The principle of this method involves continuous monitoring of out-of-plane rotation-caused scattering brightness fluctuations of the gold nanorod (AuNR) probe-based microrheometer and subsequent determination of rotational relaxation time to analyze the viscous feature in macrophage lysosomes. With this method, we demonstrated the lysosomal viscous feature as a robust pathological reporter and uncovered three distinct pathological stages underlying the evolution dynamics, which are highly correlated with a pathological stage-dependent activation of the NLRP3 inflammasome-involved positive feedback loop. We also validated the potential of this positive feedback loop as a promising therapeutic target and revealed the time window-dependent efficacy of NLRP3 inflammasome-targeted drugs against atherosclerotic diseases. To our knowledge, the pathological staging of macrophage foaming and the pathological stage-dependent activation of the NLRP3 inflammasome-involved positive feedback mechanism have not yet been reported. These findings provide insights into in-depth understanding of evolutionary features and regulatory mechanisms of macrophage foaming, which can benefit the analysis of effective therapeutical drugs as well as the time window of drug treatment against atherosclerotic diseases in preclinical studies.

摘要

巨噬细胞源性泡沫细胞的形成已被认为是动脉粥样硬化疾病的病理标志。然而,其病理演变动力学和潜在的调控机制在很大程度上仍不清楚。在此,我们通过探测溶酶体粘性特征在病理演变过程中的动态变化,引入了一种用于巨噬细胞泡沫化病理分期和抗动脉粥样硬化探索的单颗粒旋转微流变学方法。该方法的原理涉及基于金纳米棒(AuNR)探针的微流变仪对平面外旋转引起的散射亮度波动的连续监测,以及随后对旋转松弛时间的分析,以分析巨噬细胞溶酶体中的粘性特征。利用该方法,我们证明了溶酶体粘性特征作为一种强大的病理报告器,并揭示了三个不同的病理阶段,这些阶段与 NLRP3 炎性体相关的正反馈环的病理阶段依赖性激活密切相关。我们还验证了该正反馈环作为一种有前途的治疗靶点的潜力,并揭示了 NLRP3 炎性体靶向药物对动脉粥样硬化疾病的时间依赖性疗效。据我们所知,巨噬细胞泡沫化的病理分期和 NLRP3 炎性体相关的正反馈机制的病理阶段依赖性激活尚未被报道。这些发现为深入了解巨噬细胞泡沫化的进化特征和调控机制提供了思路,这将有助于分析有效的治疗药物以及临床前研究中针对动脉粥样硬化疾病的药物治疗时间窗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/b672e9e8b7c0/pnas.2403740121fig08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/260a2b2a8cee/pnas.2403740121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/5c9110b10ecc/pnas.2403740121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/38e099e703db/pnas.2403740121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/bb224955ec84/pnas.2403740121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/292fce2abeb8/pnas.2403740121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/5ed3f82c8a02/pnas.2403740121fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/5e57deb20f09/pnas.2403740121fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/b672e9e8b7c0/pnas.2403740121fig08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/260a2b2a8cee/pnas.2403740121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/5c9110b10ecc/pnas.2403740121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/38e099e703db/pnas.2403740121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/bb224955ec84/pnas.2403740121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/292fce2abeb8/pnas.2403740121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/5ed3f82c8a02/pnas.2403740121fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/5e57deb20f09/pnas.2403740121fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3f/11331104/b672e9e8b7c0/pnas.2403740121fig08.jpg

相似文献

1
Single-particle rotational microrheology enables pathological staging of macrophage foaming and antiatherosclerotic studies.单颗粒旋转微流变学可用于对泡沫巨噬细胞进行病理性分期和抗动脉粥样硬化研究。
Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2403740121. doi: 10.1073/pnas.2403740121. Epub 2024 Aug 5.
2
Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.伴侣蛋白介导的自噬缺陷促进炎症和动脉粥样硬化。
Circ Res. 2021 Dec 3;129(12):1141-1157. doi: 10.1161/CIRCRESAHA.121.318908. Epub 2021 Oct 27.
3
Copper oxide nanoparticles disrupt lysosomal function and promote foam cell formation in RAW264.7 macrophages.氧化铜纳米颗粒破坏RAW264.7巨噬细胞中的溶酶体功能并促进泡沫细胞形成。
Toxicology. 2025 May;513:154101. doi: 10.1016/j.tox.2025.154101. Epub 2025 Feb 21.
4
ClC-2 inhibition prevents macrophage foam cell formation by suppressing Nlrp3 inflammasome activation.氯离子通道-2 抑制通过抑制 Nlrp3 炎性小体激活来防止巨噬细胞泡沫细胞形成。
Biosci Biotechnol Biochem. 2020 Oct;84(10):2096-2103. doi: 10.1080/09168451.2020.1793294. Epub 2020 Jul 13.
5
p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.p38δ丝裂原活化蛋白激酶:NLRP3炎性小体激活的新型调节因子,在冠状动脉粥样硬化发生过程中表达增加
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1937-46. doi: 10.1161/ATVBAHA.115.307312. Epub 2016 Jul 14.
6
Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.褪黑素通过激活自噬和抑制 NLRP3 炎性小体来改善动脉粥样硬化的进展。
Oxid Med Cell Longev. 2018 Sep 4;2018:9286458. doi: 10.1155/2018/9286458. eCollection 2018.
7
Cathepsin B-Mediated NLRP3 Inflammasome Formation and Activation in Angiotensin II -Induced Hypertensive Mice: Role of Macrophage Digestion Dysfunction.组织蛋白酶B介导的血管紧张素II诱导的高血压小鼠中NLRP3炎性小体的形成和激活:巨噬细胞消化功能障碍的作用
Cell Physiol Biochem. 2018;50(4):1585-1600. doi: 10.1159/000494656. Epub 2018 Oct 25.
8
Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis.德斯莫甾醇可抑制巨噬细胞炎症小体激活,防止血管炎症和动脉粥样硬化。
Proc Natl Acad Sci U S A. 2021 Nov 23;118(47). doi: 10.1073/pnas.2107682118.
9
Hypoxia activates macrophage-NLRP3 inflammasome promoting atherosclerosis via PFKFB3-driven glycolysis.缺氧通过 PFKFB3 驱动的糖酵解激活巨噬细胞 NLRP3 炎性小体促进动脉粥样硬化。
FASEB J. 2024 Aug 15;38(15):e23854. doi: 10.1096/fj.202400283R.
10
P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation.P2X7R通过促进NLRP3炎性小体激活参与动脉粥样硬化的进展。
Int J Mol Med. 2015 May;35(5):1179-88. doi: 10.3892/ijmm.2015.2129. Epub 2015 Mar 9.

本文引用的文献

1
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets.巨噬细胞中的信号通路:分子机制与治疗靶点。
MedComm (2020). 2023 Sep 11;4(5):e349. doi: 10.1002/mco2.349. eCollection 2023 Oct.
2
Monitoring the Progression of Early Atherosclerosis Using a Fluorescence Nanoprobe for the Detection and Imaging of Phosphorylation and Glucose Levels.利用荧光纳米探针检测和成像磷酸化及葡萄糖水平来监测早期动脉粥样硬化的进展。
Angew Chem Int Ed Engl. 2023 Jun 19;62(25):e202302161. doi: 10.1002/anie.202302161. Epub 2023 May 9.
3
Assessing the Progression of Early Atherosclerosis Mice Using a Fluorescence Nanosensor for the Simultaneous Detection and Imaging of pH and Phosphorylation.
使用荧光纳米传感器同时检测和成像pH值与磷酸化来评估早期动脉粥样硬化小鼠的病情进展
Angew Chem Int Ed Engl. 2023 Jan 16;62(3):e202215178. doi: 10.1002/anie.202215178. Epub 2022 Dec 8.
4
The NLRP3 inflammasome: activation and regulation.NLRP3 炎性小体:激活与调控。
Trends Biochem Sci. 2023 Apr;48(4):331-344. doi: 10.1016/j.tibs.2022.10.002. Epub 2022 Nov 4.
5
Use of acidic nanoparticles to rescue macrophage lysosomal dysfunction in atherosclerosis.利用酸性纳米颗粒拯救动脉粥样硬化中巨噬细胞溶酶体功能障碍。
Autophagy. 2023 Mar;19(3):886-903. doi: 10.1080/15548627.2022.2108252. Epub 2022 Aug 18.
6
Atherosclerosis: Recent developments.动脉粥样硬化:最新进展。
Cell. 2022 May 12;185(10):1630-1645. doi: 10.1016/j.cell.2022.04.004. Epub 2022 May 2.
7
Direct Observation of Endocytosis Dynamics of Anti-ErbB Modified Single Nanocargoes.抗ErbB修饰的单个纳米载体内吞作用动力学的直接观察
ACS Nano. 2022 Apr 26;16(4):5325-5334. doi: 10.1021/acsnano.2c00184. Epub 2022 Mar 29.
8
Imaging Dynamic Processes in Multiple Dimensions and Length Scales.多维度和长度尺度的动态过程成像。
Annu Rev Phys Chem. 2022 Apr 20;73:377-402. doi: 10.1146/annurev-physchem-090519-034100. Epub 2022 Feb 4.
9
Targeting the NLRP3 inflammasome in cardiovascular diseases.针对心血管疾病中的 NLRP3 炎性小体。
Pharmacol Ther. 2022 Aug;236:108053. doi: 10.1016/j.pharmthera.2021.108053. Epub 2021 Dec 11.
10
Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome-dependent interleukin-1β production.线粒体解偶联蛋白1通过阻断NLRP3炎性小体依赖性白细胞介素-1β的产生来拮抗动脉粥样硬化。
Sci Adv. 2021 Dec 10;7(50):eabl4024. doi: 10.1126/sciadv.abl4024. Epub 2021 Dec 8.